- Report
- January 2026
- 476 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 276 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 188 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 462 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 154 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 179 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 139 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 192 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 297 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 136 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 169 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 304 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 189 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 194 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 118 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 181 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 293 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 178 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 177 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 169 Pages
Global
From €5217EUR$5,850USD£4,523GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more